Cargando…
Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
Purpose: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of anti...
Autores principales: | Désaméricq, Gaëlle, Dolbeau, Guillaume, Verny, Christophe, Charles, Perrine, Durr, Alexandra, Youssov, Katia, Simonin, Clémence, Azulay, Jean-Philippe, Tranchant, Christine, Goizet, Cyril, Damier, Philippe, Broussolle, Emmanuel, Demonet, Jean-François, Morgado, Graca, de Langavant, Laurent Cleret, Macquin-Mavier, Isabelle, Bachoud-Lévi, Anne-Catherine, Maison, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893200/ https://www.ncbi.nlm.nih.gov/pubmed/24454865 http://dx.doi.org/10.1371/journal.pone.0085430 |
Ejemplares similares
-
Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting
por: Cleret de Langavant, Laurent, et al.
Publicado: (2015) -
COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression
por: de Diego-Balaguer, Ruth, et al.
Publicado: (2016) -
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
por: Salem, Linda, et al.
Publicado: (2016) -
How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
por: Schramm, Catherine, et al.
Publicado: (2015) -
Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)